<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39511549</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>"A bit of a cough, tired, not very resilient - is that already Long-COVID?" perceptions and experiences of GPs with Long-COVID in year three of the pandemic. a qualitative interview study in Austria.</ArticleTitle><Pagination><StartPage>3078</StartPage><MedlinePgn>3078</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3078</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-20475-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long-COVID is a new multisectoral healthcare challenge. This study aims at understanding experiences, knowledge, attitudes and (information) needs that GPs had and have in relation to Long-COVID and how these evolved since the beginning of the COVID-19 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study used an exploratory qualitative research design using semistructured interviews. A total of 30 semistructured interviews with GPs in different primary care settings (single practices, group practices, primary care centres) were conducted between February and July 2022. The data were analysed using qualitative thematic content analysis with the software Atlas.ti.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This is the first study that empirically investigated Long-COVID management by GPs in Austria during the third year of the pandemic. All GPs indicated having experience with Long-COVID. In cities, GPs tended to have slightly better networks with specialists. The GPs who already worked in teams tended to find the management of Long-COVID easier. The symptoms that the physicians described as Long-COVID symptoms corresponded to those described in the international literature, but it is unclear whether syndromes and symptomes such as Post-Exertional-Malaise, autonomic dysfunction such as postural tachycardia syndrome or Mast-Cell-Overactivation-Syndrom, and cognitive dysfunctions were also recognized and correctly classified since they were never mentioned. Most GPs reacted quickly by granting the needed sick leaves and by seeing and discussing with the patients often.The treatment of the patients is described as an enormous challenge and frustrating for patient and GP if the treatment does not yield to significantly improved health also due to the high costs for the patient.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Long-COVID will continue to preoccupy our health care systems for a long time to come, as new variants of COVID-19 will continue to produce new patients without adequate prevention strategies. Therefore, it is not a question of if but when good support for GPs and adequate care pathways for people with Long-COVID will be implemented. Specific contact points that are familiar with therapy-refractory postacute infection syndromes like the postacute COVID condition as a subgroup of Long-COVID are urgently needed.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wojczewski</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Primary Care Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria. silvia.wojczewski@meduniwien.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayrhofer</LastName><ForeName>Mira</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Communication, University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szabo</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Primary Care Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabady</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Health Studies, Karl Landsteiner University of Health Sciences, Krems, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Primary Care Medicine, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="Y">General Practitioners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007407" MajorTopicYN="Y">Interviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="N">Attitude of Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">General practice</Keyword><Keyword MajorTopicYN="N">PACS</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Postacute sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">Postinfectious disease</Keyword><Keyword MajorTopicYN="N">Primary health care</Keyword><Keyword MajorTopicYN="N">Semistructured interviews</Keyword><Keyword MajorTopicYN="N">post-COVID condition</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>8</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39511549</ArticleId><ArticleId IdType="pmc">PMC11542353</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-20475-z</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-20475-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu Y, et al. Mechanisms of long COVID: an updated review. Chin Med J Pulmonary Crit Care Med. 2023;1(4):231&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11332859</ArticleId><ArticleId IdType="pubmed">39171285</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, et al. Long COVID: a clinical update. Lancet. 2024;404(10453):707&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">39096925</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19, N.I.f.H.a.C.E.C. Guidelines, Editor. London: National Institute for Health and Care Excellence (NICE); 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences, E. and, Medicine. In: Fineberg HV, et al. editors. A long COVID definition: a chronic, systemic Disease State with Profound consequences. Washington, DC: National Academies; 2024. p. 186.</Citation><ArticleIdList><ArticleId IdType="pubmed">39110819</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann K, et al. A practical Approach to Tailor the Term Long COVID for Diagnostics, Therapy and Epidemiological Research for Improved Long COVID Patient Care. Infect Dis Therapy. 2024;13(9):1921&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11343936</ArticleId><ArticleId IdType="pubmed">39127990</ArticleId></ArticleIdList></Reference><Reference><Citation>(EXPH), E. Facing the impact of post-covid-19 condition (long COVID) on health systems. Luxembourg; 2022. P.o.e.w.o.i.i.h.</Citation></Reference><Reference><Citation>Ziauddeen N, et al. Characteristics and impact of Long Covid: findings from an online survey. PLoS ONE. 2022;17(3):e0264331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M, et al. Three-year outcomes of post-acute sequelae of COVID-19. Nat Med. 2024;30(6):1564&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11186764</ArticleId><ArticleId IdType="pubmed">38816608</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, et al. The immunology of long COVID. Nature Reviews Immunology; 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28(11):2398&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert CR, et al. Post-acute Sequelae after severe Acute Respiratory Syndrome Coronavirus 2 infection by viral variant and vaccination status: a Multicenter cross-sectional study. Clin Infect Dis. 2023;77(2):194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10371307</ArticleId><ArticleId IdType="pubmed">36905145</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10644173</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T et al. Development of a definition of Postacute Sequelae of SARS-CoV-2 infection. JAMA, 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA, et al. Scientific consensus on the COVID-19 pandemic: we need to act now. Lancet. 2020;396(10260):e71&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557300</ArticleId><ArticleId IdType="pubmed">33069277</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, et al. Long covid&#x2014;an update for primary care. BMJ. 2022;378:e072117.</Citation><ArticleIdList><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Makowski L, et al. German general practitioners&#x2019; experiences during the COVID-19 pandemic and how it affected their patient care: a qualitative study. Eur J Gen Pract. 2023;29(2):2156498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10249445</ArticleId><ArticleId IdType="pubmed">36722333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ares-Blanco S, et al. Primary care indicators for disease burden, monitoring and surveillance of COVID-19 in 31 European countries: Eurodata Study. Eur J Public Health. 2024;34(2):402&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10990533</ArticleId><ArticleId IdType="pubmed">38326993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ares-Blanco S, et al. Clinical pathway of COVID-19 patients in primary health care in 30 European countries: Eurodata study. Eur J Gen Pract. 2023;29(2):2182879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10324993</ArticleId><ArticleId IdType="pubmed">36943232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmeier BE et al. How do German General practitioners Manage Long-/Post-COVID? A qualitative study in primary care. Viruses, 2023. 15(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10146752</ArticleId><ArticleId IdType="pubmed">37112996</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan A, et al. Enhancing the management of long COVID in general practice: a scoping review. BJGP Open. 2022;6(3):p&#x2013;BJGPO20210178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9680752</ArticleId><ArticleId IdType="pubmed">35256357</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R, et al. Breathing difficulties after covid-19: a guide for primary care. BMJ. 2023;381:e074937.</Citation><ArticleIdList><ArticleId IdType="pubmed">37315957</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S, et al. [S1 guidelines for the management of postviral conditions using the example of post-COVID-19]. Wien Klin Wochenschr; 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504206</ArticleId><ArticleId IdType="pubmed">37555900</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer N, Schmeck B. [Pulmonary manifestations in long COVID]. Inn Med (Heidelb). 2022;63(8):819&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9261889</ArticleId><ArticleId IdType="pubmed">35925073</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, et al. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: a consensus statement and scoping review from the global COVID-19 neuro research coalition. J Neurol Sci. 2023;454:120827.</Citation><ArticleIdList><ArticleId IdType="pubmed">37856998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann K, et al. Interdisziplin&#xe4;res, kollaboratives D-A-CH Konsensus-Statement Zur Diagnostik Und Behandlung Von Myalgischer Enzephalomyelitis/Chronischem Fatigue-Syndrom. Wiener Klinische Wochenschrift. 2024;136(5):103&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11093804</ArticleId><ArticleId IdType="pubmed">38743348</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S, et al. We literally worked in parking lots, cars, garages, and separately set up party tents: qualitative study on the experiences of GPs in the frame of the SARS-CoV-2 pandemic in Austria. BMC Health Serv Res. 2023;23(1):1394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10714610</ArticleId><ArticleId IdType="pubmed">38087337</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S, et al. Leitlinie S1: long COVID: Differenzialdiagnostik Und Behandlungsstrategien. Wiener Klinische Wochenschrift. 2021;133(Suppl 7):237&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="pubmed">34851455</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayring P. Qualitative content analysis: demarcation, varieties, developments. In Forum: qualitative Social Research. Freie Universit&#xe4;t Berlin; 2019.</Citation></Reference><Reference><Citation>van Kessel SAM, et al. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2021;39(1):159&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, et al. Long COVID science, research and policy. Nat Med. 2024;30(8):2148&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">39122965</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences, E. and, Medicine. Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection, ed. P.A. Volberding, B.X. Chu, and C.M. Spicer. 2024, Washington, DC: The National Academies Press. 264.</Citation><ArticleIdList><ArticleId IdType="pubmed">39312610</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis. 2023;23(4):393&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C et al. Fighting Post-COVID and ME/CFS &#x2013; development of curative therapies. Front Med, 2023. 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10309204</ArticleId><ArticleId IdType="pubmed">37396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection (PASC). Volume 14. PM&amp;R; 2022. pp. 1270&#x2013;91. 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538426</ArticleId><ArticleId IdType="pubmed">36169154</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Rhermoul F-Z, et al. Autoimmunity in Long Covid and POTS. Oxf Open Immunol. 2023;4(1):iqad002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10224806</ArticleId><ArticleId IdType="pubmed">37255928</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Reviews Cardiol. 2023;20(5):281&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, et al. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021;112:217&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler JB, et al. Mast cell activation is associated with post-acute COVID&#x2010;19 syndrome. Allergy. 2022;77(4):1288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9299596</ArticleId><ArticleId IdType="pubmed">34820848</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, et al. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H, Assaf G, McCorkell L. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. 10.1016. J. ECLINM, 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Arron HE et al. Myalgic Encephalomyelitis/Chronic fatigue syndrome: the biology of a neglected disease. Front Immunol, 2024. 15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11180809</ArticleId><ArticleId IdType="pubmed">38887284</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S, et al. Leitlinie S1 f&#xfc;r das Management Postviraler Zust&#xe4;nde am Beispiel Post-COVID-19. Wiener Klinische Wochenschrift. 2023;135(4):525&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504206</ArticleId><ArticleId IdType="pubmed">37555900</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamillscheg P et al. July., Barriers and facilitators of healthcare access for long COVID-19 patients in a universal healthcare system: Qualitative evidence from Austria. 18 2024, PREPRINT (Version 1) available at Research Square [10.21203/rs.3.rs-4627918/v1] 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11515580</ArticleId><ArticleId IdType="pubmed">39443935</ArticleId></ArticleIdList></Reference><Reference><Citation>Macpherson K, et al. Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review. BMJ Open. 2022;12(1):e050979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8753091</ArticleId><ArticleId IdType="pubmed">35017239</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, et al. One-year temporal changes in long COVID prevalence and characteristics: a systematic review and meta-analysis. Value in Health; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">36436792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, et al. The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization. Sci Rep. 2022;12(1):14505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9403954</ArticleId><ArticleId IdType="pubmed">36008436</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, et al. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wambeke E et al. Two-years Follow-Up of symptoms and return to work in Complex Post-COVID-19 patients. J Clin Med, 2023. 12(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917586</ArticleId><ArticleId IdType="pubmed">36769389</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med, 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381:e074425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureen Z, et al. Proposal of a food supplement for the management of post-COVID syndrome. Eur Rev Med Pharmacol Sci. 2021;25(1 Suppl):67&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">34890036</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, et al. Does Coenzyme Q10 Plus Selenium Supplementation ameliorate clinical outcomes by modulating oxidative stress and inflammation in individuals with myalgic Encephalomyelitis/Chronic fatigue syndrome? Antioxid Redox Signal. 2022;36(10&#x2013;12):729&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057907</ArticleId><ArticleId IdType="pubmed">35229657</ArticleId></ArticleIdList></Reference><Reference><Citation>Barletta MA, et al. Coenzyme Q10&#x2009;+&#x2009;alpha lipoic acid for chronic COVID syndrome. Clin Exp Med. 2023;23(3):667&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9395797</ArticleId><ArticleId IdType="pubmed">35994177</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of Post viral fatigue with Focus on Long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients, 2021. 13(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi A, Jadhav SB, Shah N. A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of Post-COVID fatigue. Med (Basel), 2021. 8(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8472462</ArticleId><ArticleId IdType="pubmed">34564089</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S, Erdos J. Long COVID care pathways: a systematic review. 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>